A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

NCT02215252 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathy, Painful

Interventions

DRUG: PF-05089771 150 mg
DRUG: Matched placebo for PF-05089771 150 mg and pregabalin 300 mg
DRUG: Pregabalin 300 mg
DRUG: PF-05089771 150 mg + Pregabalin 300 mg

Sponsor

Pfizer